openPR Logo
Press release

What's driving the Geriatric Medicines Market Size? GlaxoSmithKline Plc, BoehringerIngelheim GmbH, Novartis AG, Bristol-Myers Squibb Company, Pfizer, Inc., Eli Lilly and Company, Abbott Laboratories Inc., AstraZeneca plc, Merck & Company Inc., and Sanofi

03-24-2020 07:53 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Market Study Report LLC

Geriatric Medicines Market

Geriatric Medicines Market

Market Study Report Has Added A New Report On Geriatric Medicines Market That Provides A Comprehensive Review Of This Industry With Respect To The Driving Forces Influencing The Market Size. Comprising The Current And Future Trends Defining The Dynamics Of This Industry Vertical, This Report Also Incorporates The Regional Landscape Of Geriatric Medicines Market In Tandem With Its Competitive Terrain.

The Global Geriatric Medicines Market Size is anticipated to reach over USD 1,157.34 billion by 2026 according to a new research published by The marker research report.

Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/1695110/?utm_source=openpr.com&utm_medium=ADS

Geriatric medicines, also called geriatrics is a division of medicines associated with preventive, clinical, remedial, and social aspects of disease generally amongst people that are aged over 65 years or more. In response to the needs of an aging population, demand for geriatric medicines and appropriate cure has developed rapidly during last decades. The proper medical care for the geriatric patients across the range of ill health conditions includes co-morbid complications such as syncope, cerebral aging, and falls among others.

The global geriatric medicines market is majorly driven by the factor including a rise in geriatric populations. According to the Eurostat, the number of people aged 65 years and above is expected reach 141 million by 2050 globally.

In addition, the high market growth is expected on account of the increasing occurrence of numerous target disorders in the geriatric population, the demographic modification, the rising trend in lifestyle-associated risk aspects, and the considerably developed access to economic medicine across the developing and emerging regions. Continuous R&D activities commenced by key players and pharmaceutical companies to provide to the patient demand is expected to gain the significant outcomes during the forecast period. Increasing occurrence of chronic ailments, refining healthcare organization in emerging economies, increasing acceptance of medical tourism, government initiatives as well as support to provide timely care, and increasing number of specialty clinics are some of the other factors driving of the geriatric medicines market. However, difficulties associated with drug compatibility, lack of patient involvement in clinical trials, and side effects associated with the medications are the factors hampering the market growth.

The global Geriatric Medicines Market is segmented on the basis of therapeutic category, therapeutic condition, and geography.

On the basis of therapeutic category, the global geriatric medicines market is segmented into Analgesics, Antihypertensive, Statins, Antidiabetics, Proton Pump Inhibitor, Anticoagulant, Antipsychotic, and Antidepressant. Pain as an indication is associated with old age and the middle age population unveils the high occurrence rate of pain related syndromes. Based on current trends and the demand for proper therapy, the market is anticipated to witness high growth for therapeutic conditions during the forecast period. On the basis of therapeutic conditions, the global geriatric medicines market is segmented into Cardiovascular, Arthritis, Neurological, Cancer, Osteoporosis, and Respiratory. In 2017, the cardiovascular disease is estimated to be the dominating segment primarily due to the high proliferation of several cardiac disorders such as coronary artery disease, stroke, and hypertension.

North America is estimated to dominate the global Geriatric Medicines Market. The existence of developed healthcare facilities, favorable reimbursement policies, and the easy availability of important as well as life-saving medicine has significantly enhanced the average life expectancy rates in North America. Moreover, the number of people that are over 65 to 70 years suffering several target ailments is increasing continually which is further anticipated to boost the geriatric medicines market during the forecast period.

Some major key players in global Geriatric Medicines Market include GlaxoSmithKline Plc, BoehringerIngelheim GmbH, Novartis AG, Bristol-Myers Squibb Company, Pfizer, Inc., Eli Lilly and Company, Abbott Laboratories Inc., AstraZeneca plc, Merck & Company Inc., and Sanofi S.A. among others.

Table of Contents

Overview and Scope
1.1. Research goal & scope

1.2. Research assumptions

1.3. Research Methodology

1.3.1. Primary data sources

1.3.2. Secondary data sources

1.4. Key take-aways

1.5. Stakeholders

Executive Summary
2.1. Market Definition

2.2. Market Segmentation

Geriatric Medicines Market Insights
3.1. Geriatric Medicines - Industry snapshot

3.2. Geriatric Medicines - Ecosystem analysis

3.3. Geriatric Medicines Market dynamics

3.3.1. Geriatric Medicines - Market Forces

3.3.1.1. Geriatric Medicines Market driver analysis

3.3.1.2. Geriatric Medicines Market restraint/challenges analysis

3.3.1.3. Geriatric Medicines Market opportunity analysis

3.4. Industry analysis - Porter's five force

3.4.1. Bargaining power of supplier

3.4.2. Bargaining power of buyer

3.4.3. Threat of substitute

3.4.4. Threat of new entrant

3.4.5. Degree of competition

3.5. Geriatric Medicines Market PEST analysis, 2017

3.5.1. Geriatric Medicines Industry trends

3.5.2. Competitive Ranking Analysis

Geriatric Medicines Market Size and Forecast by Therapeutic Category
More Details on this report: https://www.marketstudyreport.com/reports/geriatric-medicines-market-by-therapeutic-category-analgesics-antihypertensive-statins-antidiabetics-proton-pump-inhibitor-anticoagulant-antipsychotic-and-antidepressant-by-therapeutic-conditions-cardiovascular-arthritis-neurological-cancer-osteoporosis-and-respiratory-and-by-regions-north-america-u-s-canada-europe-germany-uk-france-italy-russia-asia-pacific-china-india-japan-australia-latin-america-brazil-mexico-middle-east-africa-market-size-forecast-2018-2026?utm_source=openpr.com&utm_medium=ADS

Contact Info:
Market Study Report LLC
4 North Main Street,
Selbyville, Delaware 19975
USA
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Email:sales@marketstudyreport.com
Website:www.marketstudyreport.com
Blog: www.marketstudyreport.com/blog/

About Us:
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release What's driving the Geriatric Medicines Market Size? GlaxoSmithKline Plc, BoehringerIngelheim GmbH, Novartis AG, Bristol-Myers Squibb Company, Pfizer, Inc., Eli Lilly and Company, Abbott Laboratories Inc., AstraZeneca plc, Merck & Company Inc., and Sanofi here

News-ID: 1982686 • Views:

More Releases from Market Study Report LLC

COVID-19 Detection Kits Market Size o witness substantial growth during 2020-202 …
The research report on ‘COVID-19 Detection Kits market’ scrutinizes the current industry scenario to predict market size, market share, and projects valuation for different segmentations of the industry over 2020-2026. It provides business intelligence regarding various factors driving the industry growth in consort with discussing the challenges faced by the industry, and the approaches followed by market players to counter their impact. COVID-19 Detection Kits Market size to grow with
What's driving the Small Satellite Market trends? Raytheon, Lockheed Martin, Northrop Gruman, Dynetics, Surrey Satellite Technology, Axelspace, Sierra Nevada, Clyde Space, Planet Labs, Dauria Aerospace, CASC
What's driving the Small Satellite Market trends? Raytheon, Lockheed Martin, Nor …
Market Study Report LLC adds new research on Small Satellite market, which is a detailed analysis of this business space inclusive of the trends, competitive landscape, and the market size. Encompassing one or more parameters among product analysis, application potential, and the regional growth landscape, Small Satellite market also includes an in-depth study of the industry competitive scenario. The global Small Satellite market is valued at 1340 million US$ in 2018
What's driving the Antibiotics Market trends? Sanofi, Novartis AG, Pfizer Inc., Bayer AG, Abbott, Eli Lilly and Company. Johnson & Johnson Services, Inc., GlaxoSmithKline plc., Bristol-Myers Squibb Company, Astellas Pharma Inc.,
What's driving the Antibiotics Market trends? Sanofi, Novartis AG, Pfizer Inc., …
Market Study Report LLC has added a new report on Antibiotics market that provides a comprehensive review of this industry with respect to the driving forces influencing the market size. Comprising the current and future trends defining the dynamics of this industry vertical, this report also incorporates the regional landscape of Antibiotics market in tandem with its competitive terrain. The antibiotics was valued at US$ 43,348.38 million in 2019 and is
What's driving the Electrical House (E-House) Market trends? Schneider Electric, ABB, Siemens, Eaton and General Electric
What's driving the Electrical House (E-House) Market trends? Schneider Electric, …
Market Study Report LLC has added a new report on Electrical House (E-House) market that provides a comprehensive review of this industry with respect to the driving forces influencing the market size. Comprising the current and future trends defining the dynamics of this industry vertical, this report also incorporates the regional landscape of Electrical House (E-House) market in tandem with its competitive terrain. Electrical House (E-House), also called Power House, is

All 5 Releases


More Releases for Geriatric

Geriatric Care Services Market Report 2024 - Geriatric Care Services Market Size …
"The Business Research Company recently released a comprehensive report on the Global Geriatric Care Services Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. According to The Business Research Company's, The geriatric care services
Rising Geriatric Population Proliferates Precision Cardiology Industry
The precision cardiology market generates $1,011.5 million in revenue in 2021, and it is projected to grow at a rate of 12.8% from 2021 to 2030, to capture $2,998.4 million in revenue in 2030. It is ascribed to the declining cost of the sequencing methods, and rising awareness of early screening of cardiovascular diseases due to their increasing prevalence. Market Overview@ https://www.psmarketresearch.com/market-analysis/precision-cardiology-market In addition, the industry is progressing with technological advancements in
Geriatric Care Devices Market 2021 | Detailed Report
According to Market Study Report, Geriatric Care Devices Market provides a comprehensive analysis of the Geriatric Care Devices Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team. Get Free Sample PDF (including full TOC, Tables and Figures) of Geriatric Care Devices Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5042670 The report provides a
Soaring Geriatric Demographic & Sophisticated Technology Buttress Geriatric Medi …
Governments’ relentless pitch for all-round assistance for geriatric people along with technological advancements aimed at ameliorating medical assistance has underpinned the geriatric medicines market. One of the insurance programs in the United States named as the Federal Long Term Care Insurance Program has aptly incorporated near-to-full medical cost of the Americans. Factors such as longer life-expectancy, aging demographic, swelled awareness and adoption of sophisticated therapeutics are prophesized to propel the
Consistent Rise in Geriatric Population is Expected to Stimulate the Growth of G …
Geriatric population is more susceptible to chronic diseases such as heart problems, joint disorders and others. Therefore, this population group needs regular use of the medicines to prevent the disease conditions. The use of complementary and alternative medicines is increasing among the geriatric population globally due to the fact that CAMs decreases the risk of adverse reactions and drug interactions. Complementary and alternative medicines include products such as dietary medicine
Consistent Rise in Geriatric Population is Expected to Stimulate Geriatric Compl …
Geriatric Complementary and Alternative Medicines (CAM) Market: Overview Geriatric population is more susceptible to chronic diseases such as heart problems, joint disorders and others. Therefore, this population group needs regular use of the medicines to prevent the disease conditions. The use of complementary and alternative medicines is increasing among the geriatric population globally due to the fact that CAMs decreases the risk of adverse reactions and drug interactions. Browse to unlock